APA (7th ed.) Citation

Hu, X., Yang, D., Li, Y., Li, L., Wang, Y., Chen, P., . . . Hu, C. (2019). Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients. Cancer Biology & Medicine, 16(3), 556. https://doi.org/10.20892/j.issn.2095-3941.2018.0506

Chicago Style (17th ed.) Citation

Hu, Xingsheng, et al. "Prevalence and Clinical Significance of Pathogenic Germline BRCA1/2 Mutations in Chinese Non-small Cell Lung Cancer Patients." Cancer Biology & Medicine 16, no. 3 (2019): 556. https://doi.org/10.20892/j.issn.2095-3941.2018.0506.

MLA (9th ed.) Citation

Hu, Xingsheng, et al. "Prevalence and Clinical Significance of Pathogenic Germline BRCA1/2 Mutations in Chinese Non-small Cell Lung Cancer Patients." Cancer Biology & Medicine, vol. 16, no. 3, 2019, p. 556, https://doi.org/10.20892/j.issn.2095-3941.2018.0506.